Table 1.
Varies | Initial HCC | Recurrent HCC | p-value |
---|---|---|---|
No. of patients | 42 | 42 | |
Gender | 1.0 | ||
Male | 32 (76.2) | 32 (76.2) | |
Female | 10 (23.8) | 10 (23.8) | |
Age | |||
Mean | 58.2 ± 8.1 | 58.7 ± 7.9 | 0.875 |
≤ 60 years | 25 (59.5) | 23 (54.8) | 0.659 |
>60 years | 17 (40.5) | 19 (45.2) | |
Tumor size* | |||
Mean | 3.1 ± 1.3 | 2.5 ± 1.0 | 0.012 |
≤ 3 cm | 20 (47.6) | 31 (73.8) | 0.014 |
3.1–5 cm | 22 (52.4) | 11 (26.2) | |
Etiology of liver disease | 0.776 | ||
HBV | 34 (81.0) | 35 (83.3) | |
HCV | 4 (9.5) | 4 (9.5) | |
Alcoholic liver | 2 (4.8) | 2 (4.8) | |
Absence of liver disease | 2 (4.8) | 1 (2.4) | |
Liver cirrhosis | 0.763 | ||
None | 7 (16.7) | 6 (14.3) | |
Yes | 35 (83.3) | 36 (85.7) | |
Serum ALT/AST | 0.474 | ||
Normal | 31 (73.8) | 28 (66.7) | |
Elevated | 11 (26.2) | 14 (33.3) | |
Child–Pugh class | 0.355 | ||
Child-push A | 30 (71.4) | 26 (61.9) | |
Child-push B | 12 (28.6) | 16 (38.1) | |
Serum AFP level | 0.818 | ||
≤ 20 ng/ml | 27 (64.3) | 28 (66.7) | |
>20 ng/ml | 15 (35.7) | 14 (33.3) |
HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; ALT, alanine aminotransferase; AST, aspartate transaminase; AFP, alpha-fetoprotein. Numbers in parentheses are percentages.
Statistically significant.